U.S. Markets closed

Elan sells remaining stake in Alkermes

Elan (ELN) announced that Elan, through its wholly-owned subsidiary, Elan Science Three Limited, agreed to sell, on customary terms, all of its remaining 7.75M ordinary shares of Alkermes (ALKS). The sale is expected to close on February 6.